# Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)

> **NCT03833596** · PHASE4 · TERMINATED · sponsor: **McMaster University** · enrollment: 3 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Prednisone
- **DIETARY_SUPPLEMENT:** Exclusive Enteral Nutrition

## Key facts

- **NCT ID:** NCT03833596
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-25
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833596, "Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03833596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*